Senior Director, Cell Therapy Product Leader

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

The Senior Director, Cell Therapy Product Leader (CTPL) serves as the single point of accountability for product strategy across the Cell Therapy portfolio, establishing key product performance measures, setting long‑range supply, network, and technology strategies, and ensuring execution across CT Operations functions. The role serves as a strategic partner to Cell Therapy Franchise, Development, Commercial, Clinical, and Global Supply Chain leaders to align strategic aspirations and deliver sustainable product and portfolio performance.

Key performance measures include Capacity, Vector Supply, Manufacturing Success Rate (MSR), Cost of Goods Manufactured (COGM), Turnaround Time (TAT), Launch Excellence, and other critical performance indicators over a ten‑year planning horizon. The CTPL serves as the CTDO and Global Supply Chain representative within enterprise governance forums, including the Global Product Team (GPT) and Worldwide Brand Team (WWBT), driving alignment, influencing priorities, and ensuring coordinated management of work within CTDO and GSC.

The CTPL translates Product Development & Supply (PDS) and Brand strategies into integrated supply, network, and technology strategies that meet or exceed Long‑Term Financial Plan (LTFP) commitments. The CTPL leads both commercial products and development assets that have advanced beyond proof of concept and share either a therapeutic area or common technology platform. The role chairs cross‑functional GO Teams comprised of representatives from Development, MSAT, Manufacturing Operations, Supply Chain, Quality, Regulatory CMC, and Finance.

Through matrix leadership, the CTPL establishes and governs the Book of Work (BOW) required to deliver product strategy, optimize portfolio outcomes, and achieve enterprise objectives. The CTPL is accountable for shaping portfolio trade‑offs, investment needs, and risk posture across the Cell Therapy network in partnership with enterprise stakeholders and GO Team leaders. The role ensures execution of approved strategies through governance, matrix leadership, and performance management while providing oversight of the technical project portfolio required to achieve yearly product performance targets.

This includes development of integrated road‑maps, sponsorship of governance reviews, resolution of escalated risks, and stewardship of long‑range business and financial assumptions. The CTPL also leads support of supply risk events that escape through enterprise governance processes.

• Serve as the Cell Therapy Development & Operations (CTDO) and Global Supply Chain representative on Global Product Teams (GPTs) and Worldwide Brand Teams (WWBTs), ensuring alignment of priorities and coordinated execution across the enterprise.
• Own the end‑to‑end product strategy for assigned Cell Therapy assets and commercial brands, translating PDS and Brand strategies into integrated supply, network, capacity, and technology strategies that meet or exceed Long‑Term Financial Plan (LTFP) objectives.
• Chair and lead cross‑functional GO Teams, establishing, prioritizing, and governing the product Book of Work (BOW) required to deliver strategic, operational,…